Question 1

What specific improvements in walking can I expect from the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be measured during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there any risks or side effects associated with incobotulinum toxin A?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to other options I might have for managing my symptoms?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

Question 6

How often will I need to come in for assessments after receiving the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Therapeutic Benefit of Incobotulinum Toxin A for Spasticity of the Triceps Surae in Patients With Multiple Sclerosis clinical trial (NCT04265092). Contact the study team or your healthcare provider for specific answers.

What this study is about